Internal Medicine · Brooklyn, NY
NPI
1831244227
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1423 Bedford Ave
Brooklyn, NY, 11216
Phone (718) 230-5885
Groups this clinician bills Medicare through
Medicare paid, 2024
$326K
3,701 services
Medicare patients, 2024
683
Average age 76
Drug cost, 2024
$1.7M
23,655 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adebola O Orafidiya was code 99309 (snf e&m), 1,142 times for 271 patients. In total Adebola O Orafidiya billed 3,701 services in 26 codes, and Medicare paid $326K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 1,142 | 271 | $98.87 | $113K |
| 99308 SNF E&M | Facility | 793 | 239 | $65.20 | $52K |
| 99309 SNF E&M | Facility | 513 | 192 | $100.10 | $51K |
| 99232 Hospital E&M - Subsequent | Facility | 441 | 46 | $72.76 | $32K |
| 99214 Office E&M - Established | Office | 139 | 30 | $109.05 | $15K |
| 99306 SNF E&M | Facility | 136 | 112 | $158.26 | $22K |
| 99308 SNF E&M | Office | 116 | 82 | $63.92 | $7,414 |
| 99213 Office E&M - Established | Office | 78 | 38 | $73.93 | $5,767 |
| 36415 Venipuncture Blood Collection | Office | 70 | 34 | $8.65 | $606 |
| 99238 Hospital Discharge Management | Facility | 48 | 41 | $75.55 | $3,626 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 11 | $109.00 | $4,905 |
| 99306 SNF E&M | Office | 37 | 34 | $163.29 | $6,042 |
| 93000 Electrocardiogram | Office | 28 | 27 | $11.95 | $335 |
| 99222 Hospital E&M - Initial | Facility | 26 | 23 | $122.05 | $3,173 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 25 | 25 | $154.69 | $3,867 |
By year: 2022 $285K for 3,400 services; 2023 $373K for 4,427 services; 2024 $326K for 3,701 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 70 | 34 | $8.65 | $606 |
Medicare prescription drug claims, 2024
In 2024, the drug Adebola O Orafidiya prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,553 prescriptions and refills. In total Adebola O Orafidiya wrote 23,655 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,553 | 2,004 | 284 | $17K |
| Amlodipine Besylate Generic | 772 | 978 | 153 | $4,924 |
| Tamsulosin Hcl Generic | 689 | 771 | 111 | $8,394 |
| Eliquis Apixaban | 573 | 605 | 103 | $193K |
| Gabapentin Generic | 555 | 653 | 112 | $6,501 |
| Metformin Hcl Generic | 488 | 643 | 103 | $3,937 |
| Nifedipine Er Nifedipine | 456 | 552 | 79 | $8,405 |
| Levothyroxine Sodium Generic | 447 | 495 | 72 | $4,240 |
| Divalproex Sodium Generic | 436 | 444 | 35 | $11K |
| Mirtazapine Generic | 436 | 450 | 75 | $6,768 |
| Famotidine Generic | 434 | 456 | 63 | $3,873 |
| Quetiapine Fumarate Generic | 433 | 443 | 45 | $7,929 |
| Metoprolol Succinate Generic | 430 | 584 | 86 | $6,449 |
| Furosemide Generic | 424 | 456 | 76 | $2,154 |
| Losartan Potassium Generic | 409 | 469 | 79 | $3,949 |
Brand drugs: 3,205 claims; generic drugs: 20,337 claims; opioid claims: 130.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adebola O Orafidiya $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.